Tag: multiparametric MRI

Gleason 3+3 prostate cancer is often considered low-risk—so low that some experts say it shouldn’t even be called cancer at all. But could a new label change how patients view their diagnosis and choices? The answer may reshape the future of prostate cancer care. keep reading

Each year, hundreds of thousands of men undergo prostate biopsies triggered by PSA results—many of them unnecessary. New research shows that combining PSA testing with MRI can more accurately identify significant cancers while sparing men from needless biopsies and the harms of overtreatment. keep reading

Delaying or skipping PSA testing can have life-threatening consequences. New data confirms more men are being diagnosed with advanced prostate cancer when it’s too late for local treatment. Annual PSA checks can make all the difference. keep reading

Active Surveillance helps men with low-risk prostate cancer avoid overtreatment, but anxiety and repeated biopsies can take a toll. A new approach—Super Active Surveillance—combines MRI monitoring with focal therapy, offering peace of mind while keeping future treatment options open. keep reading

A recent study confirms that the new PI-FAB scoring system is highly reliable for evaluating MRI scans after focal therapy. With strong agreement among radiologists, PI-FAB offers patients and clinicians more confidence in long-term monitoring and peace of mind. keep reading

Focal therapy offers men a less invasive option with fewer side effects—but who should receive it? Updated guidelines reveal how doctors are defining the “best fit” patients, and why careful evaluation is critical to getting the best outcomes. keep reading

When facing a prostate cancer diagnosis, knowing how aggressive the disease is makes all the difference in treatment choices. A new large-scale study shows that Artificial Intelligence, working with MRI scans, may help predict tumor grade with surprising accuracy—promising more clarity for patients and their doctors. keep reading

Radiation doesn’t always mean the end of prostate cancer. Could focal therapy offer hope for recurrence? A new study on MRI-guided TULSA sheds light on benefits—and risks—that patients should know. keep reading

New tools like biomarker tests and 3T mpMRI are transforming how doctors evaluate a high PSA. Learn how these innovations reduce unnecessary prostate biopsies—saving patients from risk, stress, and costs—while delivering greater clarity in prostate cancer diagnosis. keep reading

Check out the name of this type of prostate imaging: microultrasonography. It’s a mouthful, and if you have trouble pronouncing it, you’re not alone. Let me break it down: Micro = very small. You may know words like micrometer or micromanage, same idea. Ultrasono = ultrasound. Graphy = graphics. Put it all together and it keep reading